Highlands and Islands Enterprise has pledged £2.8m of the £9.5m total investment
A new £9.5 million project awarded to Inverness life sciences firm LifeScan will secure 1,100 jobs at the Highland plant the Scottish Government has said.
Under the terms of the new deal, LifeScan, a subsidiary of Johnson & Johnson, will become the base for the US parent company's research and development of blood glucose monitoring work.
Highlands and Islands Enterprise (HIE) has pledged £2.8 million of the £9.5 million overall investment, which will also see Scotland's largest largest life sciences firm create a further 19 new roles.
Speaking during his trade mission to the US, First Minister Alex Salmond said: “This is a memorable day for life sciences in Scotland.
“We are already at the forefront of diabetes research and this commitment to LifeScan in Inverness is a further demonstration of the fact that this Highlands base will continue to be a leader in cutting-edge research.
“The research and development money will create new highly-skilled, well-paid jobs and will build on Scotland’s reputation for supporting economic growth and innovation.”
Tito Bacarese-Hamilton, research and development vice president of LifeScan, said the latest investment announcement underlines the firm's commitment to the Highlands.
He said: “We are enormously grateful for this grant, which builds on the strong partnership that we already have with Highlands and Islands Enterprise.
“It will allow us to get innovation to the market place sooner and also contribute further to the prosperity of the Highlands.”
LifeScan was created in 2001 when Johnson & Johnson acquired the UK assets of Inverness Medical Ltd, a medical device company established in 1995 to design and manufacture glucose test strips and design electronic meters for the global diabetes market.
The company has become a global leader in designing and manufacturing glucose test strips and electronic meters for monitoring diabetes, and has developed diabetes management software, control solutions and lancing devices.